Investment Research & Advisory Group, Inc.

Position in PFE — Pfizer Inc

CIK 1802136 ATLANTA, GA

Position in PFE

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$40,984

+$26,299 QoQ

Shares Held

1,702

+225.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#2,637

of 2,821 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Investment Research & Advisory Group, Inc. holds $14,457,073 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,451	$8,936,953
2	JNJ	Johnson & Johnson	18,355	$4,661,619
3	MRK	Merck & Co., Inc.	2,399	$308,271
4	ABBV	AbbVie Inc.	896	$225,469
5	AMGN	Amgen Inc	493	$178,525
6	NVO	Novo Nordisk A S	1,115	$53,453
7	GILD	Gilead Sciences, Inc.	410	$51,799
8	PFE	Pfizer Inc This page	1,702	$40,984

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,984	1,702	+225.4%	Shares	Sole	2026-07-23
2026-03-31	$14,685	523	0.0%	Shares	Sole	2026-04-20
2025-12-31	$13,022	523	-45.7%	Shares	Sole	2026-01-20
2025-09-30	$24,562	964	+0.1%	Shares	Sole	2025-10-22
2025-06-30	$23,343	963	+140.8%	Shares	Sole	2025-07-17
2025-03-31	$10,136	400	+700.0%	Shares	Sole	2025-04-21
2024-12-31	$1,326	50	+100.0%	Shares	Sole	2025-01-21
2024-09-30	$723	25	0.0%	Shares	Sole	2024-10-23
2024-06-30	$699	25	0.0%	Shares	Sole	2024-07-30
2024-03-31	$693	25	-99.9%	Shares	Sole	2024-04-17
2023-12-31	$1,073,607	37,291	-46.0%	Shares	Sole	2024-01-18
2023-09-30	$2,288,763	69,001	+3.4%	Shares	Sole	2023-10-19
2023-06-30	$2,448,610	66,756	+1.2%	Shares	Sole	2023-07-20
2023-03-31	$2,690,229	65,937	-0.2%	Shares	Sole	2023-04-19
2022-12-31	$3,385,734	66,076	-1.0%	Shares	Sole	2023-01-31
2022-09-30	$2,919,886	66,725	—	Shares	Sole	2022-10-18
No filing history on record for this holder in this stock.